MP

Meirion Puw Rees

Active Director Director DIN 10688350
DIN 10688350 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Meirion Puw Rees

Data last updated:

Meirion Puw Rees is a Director at Phastar Cro Private Limited (since 2024). The company operates in Pharma. Phastar Cro Private Limited reported revenue of ₹11.72 Cr (FY 2025).

DIN 10688350
Primary Designation Director
Industry Pharma
First Appointment 29 Jun 2024
Oldest Company Age 5 yrs
Largest company Phastar Cro Private Limited · ₹11.72 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phastar Cro Private Limited U74999KA2021FTC146096
Director29 Jun 20242021₹11.72 Cr (FY 2025)Active

Board colleagues of Meirion Puw Rees

NameDINCompanyDesignation
Meghana Bhagwat09132844Phastar Cro Private LimitedDirector

Directorship timeline

Open interactive timeline →
Phastar Cro Private Limited
Premium access

Shareholding and investment profile for Meirion Puw Rees

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meirion Puw Rees

Meirion Puw Rees currently holds 1 directorship: Phastar Cro Private Limited (Director, since 29 Jun 2024, revenue ₹11.72 Cr (FY 2025)).

Meirion Puw Rees was first appointed on 29 Jun 2024 as Director at Phastar Cro Private Limited.

The current boards of Meirion Puw Rees's companies include Meghana Bhagwat (Phastar Cro Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available